Literature DB >> 27057022

Pachyonychia Congenita Type 1: Case Report and Review of the Literature.

Praveen Kumar Rathore1, Varun Khullar1, Anupam Das2.   

Abstract

The case of an 8-year-old boy is hereby reported, who presented with nail dystrophy, subungual hyperkeratosis, oral leukokeratosis, and numerous follicular papules all over the body. The features were consistent with a diagnosis of pachyonychia congenita type 1. The case is being reported for its rarity. We also discuss in a nutshell, the literature till date.

Entities:  

Keywords:  Follicular papules; leukokeratosis; nail dystrophy; subungual hyperkeratosis

Year:  2016        PMID: 27057022      PMCID: PMC4817447          DOI: 10.4103/0019-5154.177761

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


What was known? Pachyonychia congenita is a rare genodermatosis with a wide array of cutaneous manifestations including nail dystrophy, subungual hyperkeratosis, follicular papules, oral leukokeratosis, palmoplantar keratoderma, etc.

Introduction

Pachyonychia congenita (PC) is a rare autosomal dominant disorder of keratinization.[1] It was first documented by Muller in 1904[2] followed by Jadassohn and Lewandowsky in 1906.[3] It is classified into four types, of which the two important ones include type-1 (Jadassohn–Lewandowsky type) and type-2 (Jackson–Lawler type). These are characterized by subungual hyperkeratosis, focal palmoplantar keratoderma, oral leukokeratosis, which are usually present since birth.[4]

Case Report

An 8-year-old boy born of nonconsanguineous parentage, with normal developmental milestones for his age; presented with nail defects since birth along with numerous elevated skin lesions. Family history was unremarkable. Cutaneous examination revealed dystrophic, discolored, and thickened fingernails and toenails, along with massive subungual hyperkeratosis producing a distal elevation of nail plates and wedge-shaped deformity of the nails. This resulted in the upward growth of the distal edge of the nail plates, accompanied by angulation of the lateral border [Figures 1–3]. Besides, there were numerous pin-head sized follicular papules over the entire body, concentrated over the face, back, buttocks, abdomen, and gluteal region [Figures 4–6]. Besides, hyperkeratotic lesions were distributed throughout the body. Marked hyperhidrosis of the palms and soles was observed. Palmoplantar keratoderma was present, along with painful hyperkeratotic plaques [Figures 7 and 8]. Mucosal examination was significant for the presence of asymptomatic oral leukokeratosis over the dorsum of the tongue [Figure 9]. Routine laboratory investigations including complete hemogram, hepatic profile, and renal profile were within normal limits. KOH microscopy and culture of nail clippings was negative. Skin biopsy from a hyperkeratotic lesion around elbow showed orthokeratosis and acanthosis [Figure 10]. No evidence of any malignancy was found during the thorough work up. Genetic and molecular biological studies could not be carried out due to lack of infrastructure facilities. Based on the above findings, he was diagnosed as pachonychia congenita type 1. The child was prescribed Vitamin A and E along with emolients and keratolytics. He was prescribed oral Vitamin A at a dose of 25,000 IU, under a multidisciplinary approach after consultation with Department of Pediatrics and Ophthalmology. The patient is under stringent follow-up every 2 weeks. He has been referred to the Department of Physical medicine and rehabilitation for weight control exercises.
Figure 1

Dystrophic finger nails with subungual hyperkeratosis

Figure 3

Dystrophic toe nails with wedge-shaped deformity

Figure 4

Numerous pin-head sized follicular papules over the body (anterior view)

Figure 6

Follicular papules distributed over the nose and perioral regions

Figure 7

Hyperkeratotic papules over the palms

Figure 8

Note the massive plantar keratoderma

Figure 9

Dorsum of the tongue showing leukokeratosis

Figure 10

Photomicrograph of a hyperkeratotic plaque showing massive orthokeratosis and acanthosis (H and E, ×100)

Dystrophic finger nails with subungual hyperkeratosis Close-up picture of nails showing massive subungual hyperkeratosis Dystrophic toe nails with wedge-shaped deformity Numerous pin-head sized follicular papules over the body (anterior view) Numerous pin-head sized follicular papules over the body (posterior view) Follicular papules distributed over the nose and perioral regions Hyperkeratotic papules over the palms Note the massive plantar keratoderma Dorsum of the tongue showing leukokeratosis Photomicrograph of a hyperkeratotic plaque showing massive orthokeratosis and acanthosis (H and E, ×100)

Discussion

PC is a rare genodermatosis with autosomal dominant mode of inheritance. Heterozygous mutations involving keratins K6a or K16 are associated with PC-1 whereas those involving K6B and K17 are associated with PC-2.[5] Although, autosomal dominant mode is the most common mode of inheritance, there are reports of autosomal recessive inheritance as well.[6] PC has been classified into four types, the common clinical findings in all of them being painful and debilitating plantar keratodermas, nail dystrophy and hypertrophy, oral leukokeratosis, palmoplantar hyperhidrosis, and a variety of epidermal cysts.[7] Patients with type 1 PC (Jadassohn–Lewandowsky syndrome) are characterized by the presence of nail dystrophy since birth. This may be accompanied with painful paronychia, hyperkeratosis of palms and soles over the pressure sites, oral leukokeratosis, palmoplantar hyperhidrosis, and follicular keratotic papules distributed throughout the body.[78] Besides, painful blisters also develop over the palms and soles. Another characteristic finding is the presence of verrucous lesions over the elbows, knees, popliteal fossae, and ankles. In addition, hoarseness of voice is also an important feature of PC type 1.[910] In addition to the above mentioned findings, type 2 PC (Jackson–Lawler syndrome) has the features of natal teeth, hair anomalies including pili torti, unruly hair, and bushy eyebrows. Oral leukokeratosis and palmoplantar keratoderma is milder in comparison to type 1 PC, but the development of epidermal cysts or steatocysts are the hallmark findings in type 2 PC. PC type 3 (Schafer–Branuer) has features of corneal leukokeratosis. Type 4 PC is termed as PC tarda, which is manifested in the second or third decade of life. It results from mutations in the keratins 16 and 17 genes.[11] PC with unusual features has been noted. Rare cases of pachyonychia congenita tarda have been reported with symptoms developing in the fifth decade of life.[12] Recently, a case of pachyonychia congenita associated with B-cell lymphoma has been reported.[13] Cases with unusual dental findings have also been reported.[14] An interesting case of PC with wooly hair in a 10 month old patient has been also reported.[15] Cases with isolated involvement of nails have also been described.[16] Apart from the numerous oral manifestations, median rhomboid glossitis in association with PC has been documented.[17] The clinical features in our case are suggestive of PC type 1 with characteristic subungual hyperkeratosis and follicular papules over the entire body since birth. Histological findings of orthokeratotic hyperkeratosis and acanthosis confirm our diagnosis. The patient was prescribed Vitamin A and E along with emollients and keratolytics. Mahajan et al. reported a case of PC, which was treated with oral Vitamin A and E.[18] Vitamin A stimulates differentiation and leads to normalization of accelerated epidermopoiesis of pathological keratinocytes of epidermis of skin and nail. With this background, we have prescribed Vitamin A to our patient. The upper limit of dose of Vitamin A in pediatric patients (1–8 years) is 17,500–35,000 IU. Hypervitaminosis A occurs when the consumption is more than or equal to 100,000 IU for months. Our patient was referred to Department of Pediatrics and Ophthalmology. Thereafter, he was prescribed Vitamin A at a dose of 25,000 IU. The patient is under stringent follow-up every 2 weeks, for systemic check-up including fundoscopy and signs of irritability. For management of pain and discomfort due to the palmoplantar keratoderma, patient was advised limitation of walking and standing, use of soft shoes, control of body weight, and use of appropriate clothing. The patient is under periodic follow-up. Mechanism of manipulating gene expression is now possible which in future, may help to suppress or correct the genetic defect in the chromosomes. The only effective treatment though is nail surgery with radical excision of the nail bed and matrix and grafting at the site but patient being very young, this line of treatment was not accepted by the parents.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest. What is new? Full blown cases of pachyonychia congenita are rarely found and our case is unique because it features all the classical manifestations of this rare disease. Very few cases have been reported from India.
  14 in total

1.  Pachyonychia congenita: mutations and clinical presentations.

Authors:  C S Munro
Journal:  Br J Dermatol       Date:  2001-05       Impact factor: 9.302

2.  Pachyonychia congenita tarda.

Authors:  N Mouaci-Midoun; S Cambiaghi; P Abimelec
Journal:  J Am Acad Dermatol       Date:  1996-08       Impact factor: 11.527

3.  Pachyonychia congenita with unusual dental findings: a case report.

Authors:  A R Pradeep; Chaitra Nagaraja
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-09-26

4.  Pachyonychia congenita-like nail changes treated successfully with a combination of vitamins A and E: a case report.

Authors:  B B Mahajan; A Pall; G Garg; R R R Gupta
Journal:  Indian J Dermatol Venereol Leprol       Date:  2003 Sep-Oct       Impact factor: 2.545

5.  Pachyonychia congenita tarda: A rare case report.

Authors:  Ganapathi Moger; M C Shashikanth; K T Chandrashekar; Sophia Kurein
Journal:  Contemp Clin Dent       Date:  2013-07

6.  A case with pachyonychia congenita and B-cell lymphoma.

Authors:  Vitorino Modesto dos Santos; Thiago Pereira Loures; João Daniel Bringel Rego; Christiane Aires Teixeira; Kayursula Dantas de Carvalho; Afonso Lucas Oliveira Nascimento
Journal:  Acta Med Iran       Date:  2014

Review 7.  The phenotypic and molecular genetic features of pachyonychia congenita.

Authors:  W H Irwin McLean; C David Hansen; Mark J Eliason; Frances J D Smith
Journal:  J Invest Dermatol       Date:  2011-03-24       Impact factor: 8.551

8.  Pachyonychia congenita tarda affecting only the nails.

Authors:  Mario Vaccaro; Fabrizio Guarneri; Olga Barbuzza; Claudio Guarneri
Journal:  Dermatol Online J       Date:  2008-02-28

9.  Pachyonychia congenita associated with median rhomboid glossitis.

Authors:  Julie K Karen; Julie V Schaffer
Journal:  Dermatol Online J       Date:  2007-01-27

10.  Pachyonychia congenita: A rare genodermatosis.

Authors:  Puneet Agarwal; Mahendra K Chhaperwal; Apurva Singh; Arvind Verma; Manisha Nijhawan; Kishore Singh; Dinesh Mathur
Journal:  Indian Dermatol Online J       Date:  2013-07
View more
  3 in total

1.  Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.

Authors:  Albert G Wu; Shari R Lipner
Journal:  Skin Appendage Disord       Date:  2021-02-05

2.  Author's Reply: Pachyonychia Congenita Type 1: Case Report and Review of the Literature.

Authors:  Anupam Das
Journal:  Indian J Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.494

3.  Pachyonychia Congenita: New Classification and Diagnosis.

Authors:  Manoj Kumar Agarwala; Mary E Schwartz; Frances J D Smith
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.